(15:41 GMT) Enliven Therapeutics Price Target Raised to $70.00/Share From $45.00 by Jones Trading
Dow Jones Newswires
Enliven Therapeutics Is Maintained at Buy by Jones Trading
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:ELVN
- Language
- English